Clinical Trial Update: CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy [Phase 2]

View source ↗

Summary

This clinical trial update describes the Phase 2 CompassHER2-pCR study, which investigates decreasing chemotherapy for breast cancer patients after neoadjuvant …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING